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Little is known of the process of multiplication of viruses which are patho- 
genic for animals. As a  consequence,  the  mechanism by which such agents 
increase in infected cells is largely conjectural. In contrast to the abundant 
data available on the quantitative features of multiplication of certain bacterial 
viruses, there is but little comparable information relating to animal viruses. 
Recently, with a few animal viruses, quantitative studies have been under- 
taken and the results obtained serve to illuminate certain aspects of the multi- 
plication process. It has been shown that with influenza viruses (1) or mumps 
virus  (2)  in the chick embryo, as too with pneumonia virus of mice  (PVM) 
in the mouse (3),  there occurs, after inoculation, a latent period during which 
the amount of virus does not increase. Dependent upon the virus employed, 
the duration of this period ranges from 6 hours with influenza A virus (1)  to 
24  hours with mumps virus  (2).  Mter the latent period,  there occurs an in- 
terval during which the amount of virus in infected tissue increases relatively 
rapidly. The  duration of this incremental period  ranges  from 2  hours with 
influenza A virus  (1)  to about 15 hours with PVM  (3).  Taken together, the 
latent period and the incremental period are considered to constitute a  single 
cycle of multiplication. This is succeeded by other similar discrete cycles (1-3). 
The yield of virus per cycle ranges from about a  16-fold increase in titer with 
PVM  (3)  to approximately a  50-fold increase  with influenza viruses  (1).  It 
has not been shown that these values represent the order of magnitude of the 
yield of virus per infected cell. 
Quantitative studies with PVM  (4)  demonstrated that the virus increased 
in amount in themouse lung, during the period of progressive multiplication, at 
a  constant rate regardless of the quantity of virus inoculated. Moreover, it 
was shown that the extent of pneumonia resulting from this infection increased 
at a constant rate which also was independent of the quantity of virus inocu- 
lated. Although the two rates were different, that concerned with the develop- 
ment of lung lesions being the slower, it was demonstrated that the extent of 
pneumonia was a  function of the ratio of the rates and the amount of virus 
present at a  given time during the incremental period. 
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In previous communications (5-8) the possibility has been raised that PVM 
and influenza A  virus may not utilize identical cellular metabolic systems for 
multiplication in the mouse lung. This hypothesis was developed when it was 
found that a  chemical substance, the  capsular polysaccharide of Friedl~nder 
bacillus, which  interrupts  the  multiplication of  PVM  (5,  8),  has  no  effect 
upon the multiplication of influenza A virus (6). The postulate gained support 
from the finding that the two viruses are capable of concurrent multiplication 
in the mouse lung, i.e., do not show reciprocal interference  (7). 
It appears possible that,  if  a  difference in the  multiplication processes  of 
these agents existed, it might be demonstrated directly by utilizing influenza A 
virus in quantitative studies in the mouse lung closely similar to those carried 
out with PVM (4). The results obtained in such studies are the subject of this 
communication. They indicate that influenza A  virus increases in amount at 
a constant rate in the mouse lung; that the rate is independent of the quantity 
of virus inoculated; and that the rate of increase is markedly different from that 
of PVM. The results also indicate that the extent of pneumonia induced with 
influenza A  virus in the mouse increases at a  constant rate which is not de- 
pendent on the amount of virus inoculated; and that this rate also is different 
from  that  obtained with  PVM. 
Materials and Methods 
Virus.--The PR8 strain of influenza A virus was used throughout this study. This strain 
has been through innumerable mouse lung  passages and is sufficiently  pathogenic for the mouse 
so that intranasal inoculation of a 10  -6 dilution leads to fatal disease associated with extensive 
pneumonia. A single suspension of infected mouse lungs, stored at --65°C. (9), was employed. 
This was prepared from the lungs of mice which had been inoculated 3 days previously with 
a 10-  s dilution of the PR8 strain. 
Mice.--Three  to 4 week old albino Swiss mice of The Rockefeller Institute strain were 
used. Mice were inoculated intranasaUy under light ether anesthesia, and each  received an 
inoculum of 0.05 cc. A group of 6 mice was used for each variable in all experiments. 
Infectivity  Titrations.--These  were carried out as previously described (I0) by intranasal 
inoculation of 10-fold dilutions of infected mouse lung suspension. The 50 per cent maximum 
score end-point  (10) was determined  12  days  after  inoculation. The infectivity  titers  are 
expressed in terms of the dilution of ground lung itself, i.e., a 10 per cent suspension -- 10-*. 
Hemagglutinalion  Titratlons.--Ten  per cent suspensions were prepared  by grinding in- 
fected lungs in saline for 3 minutes in a modified Waring blendor. Mixtures of equal volume s 
of lung suspension and so-called receptor-destroying enzyme (RDE),  obtained from culture 
filtrates of Vibrio cholerae (I1), were incubated at room temperature for 16 to 18 hours, and 
then at 37°C. for 2 hours after which they were centrifuged at 7,000 g for 10 minutes. Two- 
fold dilutions of the supernates  were made in 2.5 per cent sodium citrate,  and to each an 
equal volume of 0.25 per cent chicken RBC was added. Readings were made after the mixtures 
had stood  1 hour at room temperature.  The  titers  are expressed as the  reciprocal of  the 
final dilution of the lung suspension which showed the usual 2+ hemagglutination end-point 
Scoring of Lung Lesions.--Lungs were examined at autopsy and the extent of pneumonia 
estimated as described previously (10). The lung lesion score is expressed as the ratio of the 
total observed score to the maximum possible score for the group (i.e., a score of 30 for a group 
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Calc~dations.--These  were carried  out precisely as  in  the investigation on  the rates of 
multiplication and lesion development with PVM (4). The quantity of virus inoculated was cal- 
culated from the infectivity and hemagglutination titers of the inoculum, taking into account 
the dilution and the volume of the inoculum relative to the volume used in each titration. The 
number of hemagglutinating units of virus per lung was computed from the hemagglutination 
fiter of the suspension, taking into account the volumes employed. To obtain a figure for the 
maximum amount of pneumonia comparable to the maximum number of hemagglutinating 
units of virus per lung, the lesion score was multiplied by a  factor of 10 as in the previous 
study (4). 
EXPE~rMF.NTAL 
The rate of increase in viral concentration and the rate of increase in the 
amount  of pneumonia  were  studied  simultaneously  in mouse lungs  infected 
with the PR8 strain of influenza A virus. The design of the experiments was 
identical with that used in studies on pneumonia virus of mice (PVM) in the 
same host species (4). The amount of virus inoculated was varied over a wide 
range. At frequent intervals after inoculation, both the viral concentration and 
the amount of pneumonia were determined in groups of mice. Repeated ob- 
servations were made over periods sufficiently long to assure that, with each 
amount of virus inoculated, maximal values for both viral concentration and 
extent of pneumonia were reached. The concentration of virus was measured 
by the hemagglutination procedure because of its relative precision and because 
it  has  been  demonstrated  that  with  influenza  viruses  hemagglutination  is 
mused by the virus itself (12). 
A large number of mice were inoculated intranasally with dilutions of a single suspension 
of mouse lungs infected with the PR8 strain. The dilutions ranged from 10  -1 to  10  -6. The 
suspension used for the preparation of inocula had an M.S.50 infectivity titer of 10  -s.4 and a 
hemagglufination titer of 4096. Groups of 6 mice each were killed at intervals of a few hours 
after inoculation. The lungs were examined immediately and the lesions scored as described 
above. The lungs were then stored at  -28°C. until the completion of the experiment. Mice 
which died were autopsied as soon as possible and their lungs were stored at -28°C. until the 
other mice in the same group were killed. The time after inoculation was taken as the average 
time that all mice in a group survived. Suspensions were prepared of the lungs of each group 
and  treated with RDE  as described above. Hemagglutination titrations were then carried 
out in  duplicate.  Two complete experiments were carried  out with each amount of virus 
inoculated. The  results presented represent the geometric means of the hemagglutination 
titers observed at .each time interval in the two experiments and the arithmetic means of the 
two lung lesion scores observed at the same intervals. 
The results of these experiments are presented in Table I.  A  variation of 
1,000-fold,  i.e.  from 10  -1  to  10  -~,  in  the amount of PR8 inoculated did  not 
markedly affect the quantity of virus that was formed in the lungs. With such 
inocula the maximal values ranged from 3.28 to 3.82 log units per lung. With 
smaller inocula, i.e.  10  -5 or 10  -~, the maximal amounts of virus formed were of 
the order of 1/10th these values. The smaller the inoculum, the longer was the 
time required before maximal  viral  concentration developed. 138  MULTIPLICATION OF  INFLUENZA  A  VIRUS  IN  MOUSE  LUNG 
TABLE I 
Amounts of Virus and of Pneumonia in the Mouse Lung after Injection with PR8 
Virus inoeulum 0.05 cc. intranasal 
Dilution  M.S.50  Hemsgglut. 
doses  units 
10-1 
log  log 
5.4  2.4 
10  -a  ~  4.4  1.4 
I 
I 
i 
10-*  3.4  0.4 
i 
i Amount of virus in lung  Amount of pneumonia 
Time 
after  Hemag- 
inocu-  glut. titer  Units  kstion  Lesion  Score  10 per cent  per lung 
suspension 
krs.  geometric  log  L/M*  per cent 
4  64  2.08  0/30  0 
6  256  2.68  0/30  0 
8  256  2.68  0/30  0 
10  768  3.16  0/30  0 
12  512  2.98  0/30  0 
14  1024  3.28  0/30  0 
18  1024  3.28  0/30  0 
24  2048  3.58  0/30  0 
30  1780  3.52  2/30  7 
36  891  3.22  2/30  7 
48  548  3.01  3/30  10 
68  192  2.55  21/30  70 
82  96  2.25  26/30  87 
6  16  1.47  0/30  0 
10  64  2.08  0/30  0 
12  47  1.94  0/30  0 
14  128  2.38  0/30  0 
16  128  2.38  0/30  0 
18  316  2.77  0/30  0 
24  724  3.13  0/30  0 
30  1024  3.28  0/30  0 
36  1445  3.43  0/30  0 
48  1000  3.27  0/30  0 
72  1776  3.52  14/30  47 
79  2048  3.58  30/30  100 
84  1024  3.28  30/30  100 
10  8  1.17  0/30  0 
12  6  1.05  0/30  0 
14  16  1.47  0/30  0 
16  32  1.78  0/30  0 
18  96  2.25  0/30  0 
20  96  2.25  0/30  0 
24  632  3.07  0/30  0 
30  2048  3.58  0/30  0 
36  1777  3.52  0/30  0 
48  1777  3.52  0/30  0 
72  3559  3.82  7/30  23 
86  1777  3.52  30/30  100 
92  2048  3.58  24/30  80 
Lesion score 
(x lo) 
Maximum = 
lOS per lung 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
1.85 
1.85 
2.00 
2.85 
2.94 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
2.67 
3.00 
3.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
2.36 
3.00 
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TABLE I--Concluded 
Virus inoculum  0.05 cc. intmmt~l 
Time 
M.S.50 
Dilution  doses 
log 
10  -4  2.4 
after 
Henm~luL  inocu- 
umts  latiun 
log 
--0.6 
10  -6  1.4  --1.6 
10  -e  0.4  --2.6 
Amount of virus in lung  Amount of pneumonia 
Hemag- 
glut. titer  Units  Lesion  Score 
10 per cent  per lung 
~uspenglon 
geometric  log  L/M*  l~er cot! 
~tICOn 
4  O. 87  0/30  0 
256  2.68  0/30  0 
1024  3.28  0/30  0 
1024  3.28  0/30  0 
768  3.16  0/30  0 
768  3.16  14/30  47 
128  i  2.38  23/30  77 
24  1.65  28/30  93 
0  <0.27  0/30  0 
0  <0.27  0/30  0 
0  <0.27  0/30  0 
12  1.35  0/30  0 
13  ~  1.78  0/30  0 
64l  2.os  4/30  13 
128  2.38  11/3o  37 
32  1.78  21/30  70 
16  1.47  24/30  80 
16  1.47  30/30  100 
0  < O. 27  0/30  0 
0  < O. 27  0/30  0 
0  <0.27  0/30  0 
0  <0.27  0/30  0 
16  1.47  0/30  0 
48  1.95  0/30  0 
64  2.08  3/30  10 
81  1.17  7/30  23 
0  <0.27  15/30  50 
0  <0.27  11/30  37 
Lesion ~ore 
(X lo) 
Maximum = 
lOa ~r lun~ 
h, 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
2.67 
2.89 
2.97 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
2.11 
2.57 
2.85 
2.90 
3.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
<1.00 
2.00 
2.36 
2.70 
2.57 
* L =  lesion score; M =  maximum possible score. 
The extent of the pulmonary lesions which developed also was not markedly 
affected by the amount  of PR8 inoculated over a  range of 10,000-fold varia- 
tion, i.e., from 10  -1 to 10-". In all cases almost complete pulmonary consolida- 
tion was induced. When a  very small inoculum was employed, i.e.  10-  6, which 
corresponded to only 2.5  M.S.50  doses,  the maximal lesion score was 50 per 
cent, indicating that,  on the average, only half of each lung was affected and 
all mice survived. The smaller the inoculum, the longer was the time required 
before pneumonia of maximal degree developed. 
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time  after  inoculation,  as  in  Fig.  1,  a  family  of  curves  emerges.  With  the 
larger inocula, i.e.  10  -1 to 10  -q, the slopes of the curves are similar during the 
incremental period indicating  that the rate of multiplication  of the virus was 
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Fio. 1. Changes in the amount of virus and in the amount of pneumonia in the mouse 
lung as related  to time after inoculation of varying quantities  of PR8. Each experimental 
point was determined  by the results obtained  in 2 groups of 6 mice each. In each case the 
amounts of pneumonia and of virus were determined in the same lungs. 
approximately constant and independent  of the amount  of virus given. With 
small  inocula,  i.e.  10  °5 or  10  -e,  the  slopes  of the  curves are much  less steep 
and, as was indicated above, the greatest quantity of virus formed was mark- 
edly diminished. 
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extent represented by a  hemagglutination  titer of about 2048  which may be 
considered as the limiting viral concentration obtainable under these experi- 
mental conditions. When this limiting quantity was reached, a  concentration 
plateau  appeared,  the  duration  of which  depended on  the  amount  of virus 
inoculated.  In mice which  survived longer  than  100  hours,  the plateau  was 
followed by a  decremental period. The factors which are responsible  for  the 
plateau and the decremental period are not clear, but that factors other than 
specific antibodies are involved seems probable (13). 
The finding that inoculation of very small amounts of PR8,  i.e.  a  dilution 
of 10  -6 or 10-  s, did not lead to the development of maximal amounts of virus 
is consistent with  the results obtained under closely similar conditions with 
PVM (4) as also with those found with influenza A viruses by Taylor (14)  as 
well as Fazekas de St.  Groth and Donnelley (15).  Because the highest viral 
levels found with such inocula did not develop until  120 hours  and maximal 
levels observed with larger inocula did  not  persist  longer  than  96 hours,  it 
seems probable that unknown  factors associated with the decremental period 
contributed to the result. 
When the extent of the lung lesions is plotted against time after inoculation, 
another family of curves develops as is shown in Fig. 1. The slopes of the lines 
obtained with inocula of 10  -1 to  10-  4 are similar to each other, but are less 
steep  than  those  of  the  corresponding  curves  which  illustrate  the  rate  of 
increase in virus. The slopes of the lines obtained with small inocula, i.e.  10  -5 
and  10-  8, are somewhat different from the others and  appear not to be less 
steep than those of the  corresponding viral curves. It  appears then that with 
PRS, as with PVM (4), lesions developed in the  mouse lung at a  rate slower 
than that of the increase in virus whenever more than 25 M.S.50 doses of virus 
was inoculated. 
If the rate of multiplication of PR8 in the mouse lung is  constant and  in- 
dependent of the amount of virus inoculated, it would be expected that during 
the  incremental period  the  experimental points  should  approach  a  straight 
line when the quantity of virus found divided by the  amount inoculated is 
plotted against time. That this prediction is valid is demonstrated in Fig.  2. 
With inocula of 10-1 to 10  -* there is no evidence of systematic deviation from 
a straight line. However, as was to be expected from the curves shown in Fig. 
1, inocula of 10-  5 or 10  -8 did not yield comparable values. The earliest times 
that virus was demonstrable after inoculation with these small amounts were 
48 and 72 hours, respectively. It is probable that the true incremental period 
had been passed  through during these relatively long intervals and that the 
hemagglutination procedure was not sufficiently sensitive to reveal the early 
changes in the amount of virus. 
If  the  rate  of development of lung  lesions  after inoculation with  PR8  is 
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that, during the developmental period, the observed values should lie near a 
straight line if the extent of lesions divided by the amount of virus inoculated 
is plotted against time. A  test of this prediction is presented in Fig. 3. Except 
for the values obtained with an inoculum of 10  -t, there is no Systematic devia- 
tion of the experimental points from one line despite the great variation in the 
amount of  virus inoculated. 
In a quantitative study with PVM in the mouse lung (4) it was demonstrated  that the 
important variables could be equated by the expression: 
,= f-  i.  d a  (1) 
d 
3 
22 
0 
-I o//  o  10  -~ 
x  .  lO-t, 
,x  a  10  -4 
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Fro. 2. Linear relation between the amount of virus (z~) per mouse lung divided by the 
amount of PR8 inoculated  (i)  and time  after  inoculation. Experimental  points obtained 
during the incremental period are plotted. The slope of the llne, cf. equation 2, indicates that 
the amount of virus increased at a rate of 1,100-fold per day. 
in which x -- the observed value, i --- amount of virus  inoculated, t ffi time,  and bothf and 
k --- constants, and that this  equation provided a means for predicting either  the amount of 
virus or the extent of lung lesions  during the incremental period. From the data shown in 
Figs. 2 and 3, it becomes apparent that the same equation is applicable with PR8 in the 
mouse lung, for in the form: 
log  -- logf ffi 0.434.k.t  (2) 
the equation requires that a straight  line be obtained when log (x/i)  is  plotted  against t. 
Under these circumstances logf -- intercept on the y axis, and 0.434 • k -- slope of the line. 
From the line drawn through the experimental points shown in Fig. 2, in which x ffi amount 
of virus per lung (x,), it is found thatf -  0.178 and k -  7.01 when the time is converted 
to days as in the previous study (4). From the fine drawn through the observed values shown 
in Fig. 3, in which x -- amount of pneumonia per lung (xL), it is found thatf ffi 0.178 and H.  S.  GINSBERG  AND  1~.  L.  HORSFALL~  JR.  143 
k =  2.14 with time in days. The finding thatf =  0.178 in both instances indicates that approxi- 
mately 18 per cent of the virus inoculated was successful in initiating a progressive infection. 
The slopes of the lines show that the amount o1 virus increased at a rate of 1,100-fold per day; 
that the amount of pneumonia increased at a rate of 8.5-fold per day. It appears, therefore, 
that the amount of virus increased 132 times more rapidly than the amount of pneumonia. 
The ratio between  the two values of k (2.14/7.0l)  ffi 0.305, and, as was previously demon- 
strated with PVM (4), either the amount of PR8 (x,) or the amount of pneumonia (x~) in- 
duced with this agent can be computed, during the incremental period, from the equation 
log  x_.__  2  . 0.305 =  log x______z  (3) 
t,  tz 
in which t, =  time of determination of viral titer and tz ---- time of observation of extent of 
pneumonia. 
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l~o. 3. Linear relation between  the amount of pneumonia (zz) per mouse lung divided 
by the amount of PR8 inoculated (i) and time after inoculation. Experimental points obtained 
during the developmental period are plotted. The slope of the line, cf.  equation 2, indicates 
that the amount of pneumonia increased at a rate of 8.5-fold per day. 
DISCUSSION 
The results obtained in this investigation provide direct evidence that  the 
multiplication process of influenza A  virus, PR8 strain, in the mouse lung is 
different from that of pneumonia virus of mice, PVM,  (4) in the same tissue. 
Although there is, as yet, very little information regarding the cellular metabolic 
processes which are associated with the multiplication of either PR8 or PVM 
in the lung of the mouse,  the finding that certain measurable features of the 
incremental  period  are  strikingly dissimilar provides  additional  support  for 
the hypothesis which led to the present study. In this connection, it should be 
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that the citric acid cycle was essential for the multiplication of PR8 in the mouse 
lung. The relation of reactions of the Krebs cycle to the multiplication of PVM 
has not yet been determined. 
It appears evident that the equations which were developed to relate the 
controllable variables and to test the predictability of experimental findings 
with PVM  (4)  serve to relate the variables examined in the PR8 mouse lung 
system and  make feasible  the  prediction  of  observed  results.  It  should  be 
emphasized that the chief function utilized, i.e.  equation  1,  in this and  the 
preceding  study  (4),  was  developed  from  theoretical considerations  on  the 
assumption that infection of an host cell with a virus leads to the development 
of a  relatively constant number of new viral particles which on release from 
that cell can each infect another host cell and repeat the developmental cycle. 
The evidence obtained in this investigation provides support for the validity 
of this assumption with respect  to the multiplication of PR8  in the mouse 
lung. 
From the data obtained in the present study and  that which preceded it 
(4),  the following quantitative differences in  the processes of multiplication 
of PR8 and PVM in the mouse lung emerge: (a) with PR8 the inoculated virus 
appears  to be  60  times more efficient than PVM  in initiating a  progressive 
infection; (b)  with PR8 the amount of virus increases about 139 times more 
rapidly than PVM; (c) pneumonia induced with PR8 increases approximately 
1.8 times faster than that induced with PVM; and (d) with PR8 the amount 
of virus increases about 130 times more rapidly than the amount of pneumonia 
while with PVM the ratio of the same two rates is 1.7. 
In a  recent communication (17)  on the effects of Newcastle disease virus 
in  the  mouse  lung,  the  hypothesis was  developed  that  factors other  than 
viral multiplication per se may contribute to the induction of pulmonary lesions. 
The findings obtained in the present study appear to afford independent support 
for this  concept. The  fact  that  the  rate of increase in the amount of PR8 
is so markedly different from that of PVM  (4),  whereas the rate of develop- 
ment of pneumonia induced with PR8 is not greatly different from that in- 
duced with PVM, suggests that the multiplication process is not the only factor 
upon which the appearance of lesions depends. 
SUMMARY 
Influenza A virus, PR8 strain, increases in amount in the infected mouse lung 
at a  relatively constant rate.  When more  than 25  M.S.50  doses of virus is 
inoculated, the rate of multiplication appears to be independent of the amount 
of virus introduced; has a  value of  1,100-fold  increase per day. The rate of 
increase in the pulmonary lesions induced by infection of the mouse lung with 
PR8 also appears  to be relatively constant and independent of the amount 
of virus inoculated; has a value of 8.5-fold increase per day. H.  S.  GINSBERG  AND  F.  L.  tIORSFALL,  JR.  145 
The essential variables in the PR8-mouse lung system appear to be equated 
satisfactorily by functions which were derived previously (4) during a  similar 
quantitative investigation on pneumonia virus of mice  (PVM).  Evidence in 
support  of the  hypothesis that  the processes  of multiplication of PR8  and 
PVM are different in the mouse lung is presented. 
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